13 unknown, 4 completed, 4 recruiting, 3 not yet recruiting. 10 Phase 4, 8 Phase 2, 5 Not applicable, 2 Phase 1, 1 Phase 3.
Follow iguratimod: new trials by email Literature Review of iguratimod trials Research Report on iguratimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis Huoluo Pills, Iguratimod Tablets - Rheumatoid Arthritis | Not applicable | Not yet recruiting | Wangjing Hospital, China Academy of Chinese Medical Sciences | 240 | 2025-08-11 | 2025-08-11 |
| A Study of Iguratimod in Combination With Tofacitinib in RA Patients Combined therapy of Iguratimod and tofacitinib - Rheumatoid Arthritis (RA | Phase 4 | Not yet recruiting | Jie Chang | 200 | 2025-08-01 | 2025-04-25 |
| Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP Iguratimod, low-dose rituximab - Immune Thrombocytopenia (ITP) | Phase 2 | Not yet recruiting | Peking University People's Hospital | 120 | 2025-07-01 | 2025-07-10 |
| Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD Iguratimod - cGVHD | Phase 1 / Phase 2 | Recruiting | Xuzhou Medical University | 20 | 2024-01-10 | 2026-09-30 |
| Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement glucocorticoid plus iguratimod, glucocorticoid plus leflunomide - Autoimmune Diseases | Not applicable | Recruiting | Peking Union Medical College Hospital | 60 | 2022-07-01 | 2026-04-07 |
| Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Iguratimod - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 100 | 2022-03-22 | 2022-03-31 |
| Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO) Iguratimod, placebo - Hand Osteoarthritis, Inflammatory Arthritis | Phase 2 / Phase 3 | Unknown | Peking University People's Hospital | 150 | 2022-03-01 | 2022-02-08 |
| The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets - Primary Sjögren's Syndrome | Phase 4 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 78 | 2022-01-14 | 2024-10-16 |
| The Clinical Efficacy of Immunomodulators in RA Patients Iguratimod, Methotrexate, Adalimumab Injection - Arthritis, Rheumatoid | Phase 4 | Recruiting | Qilu Hospital of Shandong University | 400 | 2021-12-22 | 2022-11-29 |
| The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Iguratimod, Danazol - ITP, Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 120 | 2021-09-01 | 2022-05-02 |
| Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis Iguratimod - Rheumatoid Arthritis, Therapy | Phase 4 | Unknown | Yanfeng Hou | 117 | 2021-06-01 | 2024-03-25 |
| A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. Iguratimod, Placebo - Primary Sjögren Syndrome | Phase 2 | Unknown | Jiangsu Simcere Pharmaceutical Co., Ltd. | 144 | 2021-03-22 | 2021-07-19 |
| Iguratimod in Systemic Sclerosis Iguratimod, Placebo - Systemic Sclerosis, Diffuse | Not applicable | Unknown | RenJi Hospital | 20 | 2021-01-01 | 2020-08-17 |
| The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA Iguratimod, Tofacitinib, Pred - Arthritis, Rheumatoid | Phase 4 | Completed | Qilu Hospital of Shandong University | 100 | 2020-03-01 | 2023-11-18 |
| The Iguratimod Effect on Lupus Nephritis (IGeLU) Iguratimod, Cyclophosphamide, Azathioprine - Lupus Nephritis | Phase 2 | Unknown | RenJi Hospital | 120 | 2017-09-07 | 2018-12-19 |
| Iguratimod as Treatment for Refractory Lupus Nephritis Iguratimod - Lupus Nephritis | Not applicable | Unknown | RenJi Hospital | 30 | 2017-05-08 | 2017-02-27 |
| Study of Iguratimod in Sjögren's Syndrome Iguratimod - Sjogren's Syndrome | Phase 1 / Phase 2 | Unknown | Peking Union Medical College Hospital | 30 | 2017-02-01 | 2017-01-18 |
| Iguratimod in Kidney Transplant Recipients Iguratimod, Mycophenolate mofetil, Tacrolimus - Kidney Transplantation | Not applicable | Unknown | The First Affiliated Hospital with Nanjing Medical University | 60 | 2016-08-01 | 2018-08-29 |
| The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment Iguratimod, MTX, HCQ - Arthritis, Rheumatoid | Phase 4 | Completed | Qilu Hospital of Shandong University | 400 | 2016-01-01 | 2023-11-18 |
| Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis Iguratimod, Leflunomide, Methotrexate - Rheumatoid Arthritis | Phase 4 | Unknown | Jiangsu Simcere Pharmaceutical Co., Ltd. | 240 | 2013-09-01 | 2014-10-27 |
Showing 20 of 24. Sign in to see all of them.
Arthritis, Rheumatoid (11) · Purpura, Thrombocytopenic, Idiopathic (3) · Arthritis (2) · Lupus Nephritis (2) · Sjogren's Syndrome (2) · Autoimmune Diseases (1) · Immunoglobulin G4-Related Disease (1) · Nephritis (1) · Recurrence (1) · Scleroderma, Diffuse (1)
Jiangsu Simcere Pharmaceutical Co., Ltd. (5) · Peking University People's Hospital (4) · Qilu Hospital of Shandong University (3) · RenJi Hospital (3) · Peking Union Medical College Hospital (2) · Eisai Co., Ltd. (1) · Jie Chang (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Wangjing Hospital, China Academy of Chinese Medical Sciences (1) · Xuzhou Medical University (1) · Yanfeng Hou (1)
China (20) · Japan (1)
Chunde Bao, MD (2) · Xiao-Hui Zhang, MD (2) · Akiko Yoshimura (1) · Hongzhi Wang (1) · Jieruo Gu, Doctor (1) · Min Gu (1) · Ming Lv, Dr. (1) · Wen Zhang, MD (1) · Xiaohui Zhang (1) · Xiaoyun Yang (1) · Xiaoyun Yang, Dr. (1) · Yan Zhao, Dr. (1) · Yanfeng Hou, Dr. (1) · Ying Guan (1) · Yongmei Han (1)
PMID 27919207, PMID 34327344, PMID 34380536, PMID 39056160, PMID 41423293